Prof. Hu Dayi
Chair of AIRS Asia, Advisory Board of the Conference
Hu Dayi, MD, FACC, FESC is Chief of the Intervention Center at Peking University People’s Hospital, Dean of Clinical Research Institute at Shanghai’s Fudan University, President of the Chinese Society of Cardiology (CSC), President of the China Committee of Cardio-Cerebral-Vascular Diseases of GSC.
Prof. Hu Dayi speaks about: "The Demand for Cardiac Rehabilitation in China and Standardization"
He is also the past president of the Chinese College of Cardiovascular Physicians (CCCP), and a member of the International Academy of Sciences for Europe and Asia (IASEA).
Professor Dayi Hu was born in the Henan province of Central China, in 1946. He graduated from Beijing Medical School (now Peking University Health Science Center) in 1970 and furthered his education both at SUNY-Oswego and University of Illinois from 1985-1987. Professor Hu has been a pioneer of radio-frequency ablation technology in the treatment of tachyarrhythmia. Since 1980, he had actively shared his work with more than 160 hospitals in China along with a few in India, Vietnam and Japan. He has specialized in preventive cardiology, electrophysiology, pacemaker implantation and interventional therapy of coronary artery disease. He also actively studies the treatment and prevention of hypertension, coronary heart disease, heart failure and channelopathy. He has been recognized with a number of awards, such as “National Prize for Progress in Science and Technology” (twice), “Chinese physicians award” and “Beijing Advanced Science Workers”, to name a few. Currently, he actively participates in the management and prevention of cardiovascular disease and comprehensive interdisciplinary research on a national level. He is the principal investigator (PI) of the China Heart Survey, the Steering Committee member of many international clinical trials such as ROCKET, BEAUTIFUL, GARFIELD, SHIFIT, SAVE, ACE, MAGELLAN, SIGNIFY, ALECARDIO, Dal-HEART,TIMI 54, etc.
Professor Hu is a member of the Board of Directors of the International Society of Cardiovascular Pharmacotheraphy (ISCP), the editor-in-chief of Chinese Journal of Cardiology, an international board member of Journal of Clinical Cardiology, Journal of the American College of Cardiology, European Heart Journal, Nature Cardiovascular Medicine and also many other national and international medical journals.
Professor Hu has been the editor-in-chief or major translator of 50 professional books, three of which have been published in United States. He has published more than 500 papers in journals at home and abroad. Between 1989 to 2011, 82 Master degree candidates, 34 doctoral candidates and 19 post- doctoral candidates from three different medical schools have graduated under the supervision of Professor Hu, many of them currently holding prestigious positions around the country. Professor Hu has presided over more than 30 international conferences. Professor Hu has made tremendous contributions in promoting Chinese Cardiac Pacing and Electrophysiology, Chinese preventive cardiology and has been a huge proponent of Health Education in China.